Effort to understand cellular functions promises to unlock crucial information about personal health
Group, which has faced multiple US lawsuits, hit with fresh claims that its products caused cancer
Robert F Kennedy Jr’s appointment is characteristic of Trump’s hostility to expertise
Simon Kuper and Anjana Ahuja select their must-read titles
UK company says launch of chewable goods, presence in supermarkets and anti-obesity drugs have driven demand
Danish company expects data to show that CagriSema cuts weight by 25 per cent in just over a year
This week’s issue takes in revolutionary supplements, rare Scandi maximalism – and a reactionary restaurant that wants to go back in time
New York Times has sued European Commission over its refusal to release president’s exchanges with Pfizer chief
Vaccine sceptic and former Democrat is the latest controversial nomination for cabinet post
As anxieties about mental health increase, many headteachers are prohibiting phone use for students. Should the government make that mandatory?
Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
The bathhouse is back, from old-school hang-outs to sleek new spas
We go to the source of a 30mn-strong phenomenon
In-house counselling is becoming more common, but the country’s high-pressure corporate culture persists
People prone to breast cancer and diabetes among beneficiaries of early testing
Data suggests that the long-term drag on health service delivery may be finally lifting
Heathcare software provider is cutting waiting times, discharge times — and millions of pounds of costs
High levels of post-pandemic absenteeism are creating problems for employers
Research has shown a link between social media apps and eating disorders, depression and anxiety among young people
It’s the super-supplement that claims to help you sleep, perform and focus. We put the latest form to the test
Labour MP’s proposed legislation sets out that end-of-life applications would have to go before a High Court judge
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms
Studies show strong links between photo-centric social media and eating disorder pathology
MPs will soon vote on whether the terminally ill can end their lives. The decision is fraught with logistical and ethical questions
The Global Wellness Institute estimates that the sector could be worth $913bn by the end of 2028. It’s a big development for what was once regarded as ‘woo-woo’
